Merck KGaA division collaborates on MS treatments
Hays Pharma - London,Greater London,UK
Merck Serono, a Merck KGaA division, has announced that it is teaming up with Bionomics to work on new treatments for multiple sclerosis (MS). ...
See all stories on this topic

Band Against MS Awards Research Scholarship
antiMUSIC.com - CA,USA
The scholarship, issued through The Foundation of the Consortium of Multiple Sclerosis Centers (FCMSC), was awarded to UT Houston Medical School student, ...
See all stories on this topic

Lemonade stand in Belk to help MS clients, research
Charleston Post Courier - Charleston,SC,USA
Wolff's son, Justin Harl, is one of more than 500000 people nationwide who live with multiple sclerosis. Her stand is part of a special fundraising program ...
See all stories on this topic

Edwards golf tourney raises money for multiple sclerosis
Vail Daily News - Vail,CO,USA
Proceeds from the June 9 event will fund the Edwards-based Heuga Center for Multiple Sclerosis’ health and wellness programs that are designed to help ...
See all stories on this topic

MS Society looks to double their biking numbers for their 2008 MS ...
MediaSyndicate (press release) - USA
Melville, NY, 2008 - The National Multiple Sclerosis Society, Long Island Chapter set an aggressive goal of doubling their biker participation for this ...
See all stories on this topic

MS Society to fund physiotherapists
Barchester Healthcare - London,UK
The Multiple Sclerosis (MS) Society has announced plans to fund a number of specialist MS physiotherapist posts across the UK. The Multiple Sclerosis (MS) ...
See all stories on this topic

Wife's website manages illness
Auckland stuff.co.nz - Auckland,New Zealand
By HAYDEN DONNELL - North Shore Times | Thursday, 19 June 2008 NEW MESSAGE: The effect of multiple sclerosis on Tim Preston's memory inspired his wife ...
See all stories on this topic

---

Icahn Nominee to Biogen Idec Board Pledges to Work With Current ...
Xconomy - Cambridge,MA,USA
... partnership and Biogen’s partnership with Elan Pharmaceuticals on the multiple sclerosis and Crohn’s disease drug Tysabri could be strengthened. ...
See all stories on this topic

Merck Serono signs licensing agreement with Bionomics on multiple ...
Forbes - NY,USA
GENEVA (Thomson Financial) - Merck KGaA's unit Merck Serono said it signed a development and licensing agreement with Bionomics Ltd., under which Merck ...
See all stories on this topic

Teva's new blockbuster drug?
Globes - Rishon Le-Zion,Israel
Clal Finance Batucha analyst Gal Reiter says that Teva now has a second original drug alongside Copaxone. "If we previously estimated Azilect sales at $300 ...
See all stories on this topic